Concurrent hypertension and obesity and the risk of incident heart failure: insights from 2 prospective cohort

Dongjie Du1, Yitian Chen1, Weilan Li1

  • 1Department of Cardiology, Beijing Friendship Hospital, Capital Medical University, Beijing, China.

Insights

Hypertension and obesity together significantly increase heart failure (HF) risk. This risk is highest when both conditions coexist, even in early stages, highlighting the need for integrated management strategies.

Area of Science:

  • Cardiovascular Medicine
  • Public Health
  • Epidemiology

Background:

  • Investigates the combined impact of hypertension and obesity on incident heart failure (HF).
  • Assesses the clinical obesity definition proposed by The Lancet Diabetes & Endocrinology Commission for feasibility.

Purpose of the Study:

  • To examine the association between coexisting hypertension and obesity with incident heart failure (HF).
  • To evaluate the feasibility of a novel clinical definition of obesity.

Main Methods:

  • Utilized data from the UK Biobank (n=444,754) and Tongzhou Cohort (n=10,459).
  • Defined hypertension via diagnosis, blood pressure, or treatment; assessed obesity using BMI, central, combined, and clinical definitions.
  • Employed Kaplan-Meier curves and multivariable Cox models to estimate HF risk.

Main Results:

  • Coexisting hypertension and obesity consistently showed the highest HF risk across various obesity definitions.
  • Prevalence of combined hypertension and obesity ranged from 18.0% to 37.3% across cohorts.
  • Elevated blood pressure and pre-obesity increased HF risk even in individuals without diagnosed hypertension or obesity.

Conclusions:

  • Combined hypertension and obesity represent a significant risk factor for heart failure.
  • The elevated risk associated with these conditions is observable even at preclinical stages.
  • The findings support the clinical relevance of assessing both hypertension and obesity for HF risk prediction.
Abstract

Related Concept Videos

Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
1.6K
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
747
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
1.3K
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.4K
Hypertension I: Introduction01:28

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
1.2K
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
3.7K